Northern Trust’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183M Sell
3,808,735
-194,587
-5% -$8.52M 0.02% 514
2025
Q4
$155M Sell
4,003,322
-71,917
-2% -$2.74M 0.02% 571
2025
Q3
$144M Buy
4,075,239
+53,389
+1% +$1.93M 0.02% 595
2025
Q2
$145M Buy
4,021,850
+1,045,593
+35% +$34.6M 0.02% 577
2025
Q1
$92.7M Sell
2,976,257
-354,172
-11% -$11.2M 0.01% 742
2024
Q4
$85M Buy
3,330,429
+376,619
+13% +$9.99M 0.01% 801
2024
Q3
$83.6M Sell
2,953,810
-343,467
-10% -$9.51M 0.01% 732
2024
Q2
$86.9M Buy
3,297,277
+484,144
+17% +$13.4M 0.01% 696
2024
Q1
$85.4M Buy
2,813,133
+178,958
+7% +$5.28M 0.01% 689
2023
Q4
$74M Buy
2,634,175
+36,226
+1% +$996K 0.01% 760
2023
Q3
$70.5M Buy
2,597,949
+224,261
+9% +$6.66M 0.01% 740
2023
Q2
$73M Sell
2,373,688
-104,040
-4% -$3.52M 0.01% 723
2023
Q1
$89.3M Buy
2,477,728
+48,275
+2% +$1.79M 0.02% 642
2022
Q4
$96M Buy
2,429,453
+78,769
+3% +$3.29M 0.02% 596
2022
Q3
$94.5M Sell
2,350,684
-32,350
-1% -$1.38M 0.02% 563
2022
Q2
$100M Sell
2,383,034
-25,650
-1% -$1.05M 0.02% 562
2022
Q1
$93.8M Buy
2,408,684
+147,062
+7% +$5.77M 0.02% 668
2021
Q4
$90.1M Buy
2,261,622
+592,948
+36% +$23M 0.01% 713
2021
Q3
$60.3M Buy
1,668,674
+450,183
+37% +$17.5M 0.01% 946
2021
Q2
$49.9M Sell
1,218,491
-87,142
-7% -$3.71M 0.01% 1139
2021
Q1
$57M Buy
1,305,633
+558,274
+75% +$26.5M 0.01% 1017
2020
Q4
$37.4M Buy
747,359
+197,318
+36% +$8.37M 0.01% 1320
2020
Q3
$23.1M Buy
550,041
+391,165
+246% +$16.8M 0.01% 1514
2020
Q2
$7.71M Buy
+158,876
New +$7.86M ﹤0.01% 2264

Other funds holding RPRX